Large pharma companies at PMWC 2027

Jan 27–29, 2027 Santa Clara, CA ~3k attendees Website

16 large pharma companies are at PMWC 2027 — 31 presentations on the program and 1 with a booth in the exhibit hall. Most represented: Genentech (5 on the program), Amgen (3 on the program), Eli Lilly (3 on the program). 4 of them have their own page in this guide. As of Nov 10, 2026.

All 296 organizations at PMWC 2027 →

Topic
Top represented
Showing 1–14 of 16 organizations
OrganizationPMWC 2027 Attendance
Genentech
South San Francisco, CA
Large pharma
Biotechnology company and member of the Roche Group, with marketed medicines in oncology, immunology, neuroscience and ophthalmology.
PMWC Pioneer Award honoree
Panel
Wed Jan 27
9:30am
Part of Track 5: Spatial Biology and Tissue Architecture
The Next Map of Biology: From the Human Genome to the Human Cell Atlas in the AI Era
with Broad Institute, Massachusetts General Hospital
Panel
Wed Jan 27
11:00am
Part of Track 1: Engineered Cell and Gene Therapy Platforms
AI in Cell Therapy: Research to Commercialization
with Aspen Neuroscience, Benchling, Kite Pharma
Panel
Wed Jan 27
11:00am
Part of Track 5: Spatial Biology and Tissue Architecture
Spatial Proteomics: From Cell States to Therapeutic Targets
with Stanford University
Panel
Thu Jan 28
1:00pm
Part of Track 5: Precision Immunology: Autoimmune & Inflammatory Disease
Turning Biomarkers on Their Head: What We Can Measure Before We Can Predict
with UCSF, Stanford University, Yale University +1 more
Panel
Thu Jan 28
4:30pm
Part of Track 2: Clinical AI: Deployment, Decision Support and RWE
Pharma Scaling — From Pilots to Enterprise AI
with Takeda, Pfizer
Amgen
Thousand Oaks, CA
Large pharma
Biotechnology company with marketed medicines in oncology, inflammation, cardiovascular and bone disease, and a large research and development pipeline.
PMWC Pioneer Award honoree
Panel
Thu Jan 28
11:00am
Part of Track 4: Integration & Implementation of Precision Medicine
What Gets Covered and Why
with Rubrum Advising, EmblemHealth
Panel
Thu Jan 28
3:30pm
Part of Track 3: Liquid Biopsy – Therapy Guidance & Monitoring
MRD as a Surrogate Endpoint for Accelerated Drug Approval: Successes and Challenges
with University of Miami, Virginia Tech, Merck +4 more
Panel
Fri Jan 29
9:30am
Part of Track 1: Programmable Genetic Medicines
Programming Protein Fate: Molecular Glues, Degraders, and Induced Proximity
with Nurix Therapeutics, Stanford University
Eli Lilly
Indianapolis, IN
Large pharma
Global pharmaceutical company with medicines in diabetes and obesity, oncology, immunology and neuroscience, and a growing genetic medicine effort.
Panel
Thu Jan 28
2:00pm
Part of Track 5: Precision Immunology: Autoimmune & Inflammatory Disease
Precision Immunology in Clinical Development
with Merck, Kite Pharma, AltruBio +2 more
Panel
Thu Jan 28
2:30pm
Part of Track 1: Immunotherapies & Targeted Therapies
Which Immune Cells Can Be Programmed In Vivo, and for What Purpose?
with UCSF, University of Pennsylvania
Panel
Fri Jan 29
11:00am
Part of Track 2: AI in Drug Discovery & Computational Biology
Data Is the Moat: Who Wins the AI Drug Race?
with Chai Discovery, Broad Institute, Noetik +3 more
Roche
Basel, Switzerland
Large pharmaExhibitor
Global healthcare company combining pharmaceuticals and diagnostics, from cancer medicines to lab instruments and tissue tests.
Booth
Exhibiting at Booth D1139
Track
Wed Jan 27
All day
Track 2: Multimodal AI in Diagnostics
Track chair
Panel
Wed Jan 27
1:15pm
Part of Track 2: Multimodal AI in Diagnostics
Fireside Chat
with DeepLearning.AI
Panel
Wed Jan 27
1:45pm
Part of Track 2: Multimodal AI in Diagnostics
The Precision Oncology Operating System
with Massive Bio, Tempus AI, City of Hope
Panel
Fri Jan 29
2:00pm
Part of Track 3: Blood-Based Diagnostics Beyond Cancer
From Signal to Standard of Care: What Makes a Non-Cancer Blood Test Actionable?
with Cepheid, Network Bio
AstraZeneca
Cambridge, UK
Large pharma
Global pharmaceutical company with medicines in oncology, cardiovascular, renal, respiratory, immunology and rare disease.
Panel
Wed Jan 27
1:00pm
Part of Track 1: Engineered Cell and Gene Therapy Platforms
In Vivo Delivery: The Make-or-Break Layer
with Umoja Biopharma, Kite Pharma, RA Capital +1 more
Panel
Thu Jan 28
11:15am
Part of Track 3: Liquid Biopsy – Therapy Guidance & Monitoring
Advanced Cancer and Recurrence: Monitoring Response, Detecting Resistance, and Knowing When to Switch
with Stanford University, Johns Hopkins University, Quest Diagnostics +2 more
Large pharma
Global pharmaceutical company with medicines in oncology, hematology, immunology, cardiovascular disease and neuroscience, including cell therapies.
Panel
Thu Jan 28
9:45am
Part of Track 5: Precision Immunology: Autoimmune & Inflammatory Disease
Immune Reset in Autoimmune Disease: CAR-T, in vivo CAR, and Drug-Free Remission
with Harvard University, RA Capital, UCSF +1 more
Panel
Fri Jan 29
9:30am
Part of Track 2: AI in Drug Discovery & Computational Biology
From Human Evidence to Better Medicines: Choosing the Right Targets
with Valo Health, Novartis, Genscience +2 more
Merck
Rahway, NJ
Large pharma
Global pharmaceutical company, MSD outside the US and Canada, with medicines in oncology, vaccines, immunology and infectious disease.
Panel
Thu Jan 28
2:00pm
Part of Track 5: Precision Immunology: Autoimmune & Inflammatory Disease
Precision Immunology in Clinical Development
with Eli Lilly, Kite Pharma, AltruBio +2 more
Panel
Thu Jan 28
3:30pm
Part of Track 3: Liquid Biopsy – Therapy Guidance & Monitoring
MRD as a Surrogate Endpoint for Accelerated Drug Approval: Successes and Challenges
with University of Miami, Virginia Tech, Amgen +4 more
Pfizer
New York, NY
Large pharma
Global pharmaceutical company with medicines and vaccines across oncology, inflammation, rare disease and infectious disease.
Panel
Wed Jan 27
2:15pm
Part of Track 2: Multimodal AI in Diagnostics
AI and Omics Foundation Models Powering Translational Research
with NVIDIA, Data4Cure
Panel
Thu Jan 28
4:30pm
Part of Track 2: Clinical AI: Deployment, Decision Support and RWE
Pharma Scaling — From Pilots to Enterprise AI
with Takeda, Genentech
Also
Presenting at the meeting, beyond the sessions above
Large pharma
Global oncology company, formerly BeiGene, with marketed cancer medicines and a pipeline of small molecules, antibodies and other therapies.
Panel
Thu Jan 28
9:45am
Part of Track 1: Immunotherapies & Targeted Therapies
Precision Immunotherapy After PD-1: Cells, Bispecifics, ADCs, and Beyond
with MD Anderson Cancer Center, UCLA, Cancer Research Institute +2 more
Biogen
Cambridge, MA
Large pharma
Biotechnology company with marketed medicines for neurological and immunological diseases, including multiple sclerosis and spinal muscular atrophy.
Panel
Thu Jan 28
9:45am
Part of Track 5: Precision Immunology: Autoimmune & Inflammatory Disease
Immune Reset in Autoimmune Disease: CAR-T, in vivo CAR, and Drug-Free Remission
with Harvard University, Bristol Myers Squibb, RA Capital +1 more
Daiichi Sankyo
Tokyo, Japan
Large pharma
Global pharmaceutical company focused on oncology, best known for its antibody-drug conjugates, plus cardiovascular and other medicines.
Panel
Thu Jan 28
9:45am
Part of Track 1: Immunotherapies & Targeted Therapies
Precision Immunotherapy After PD-1: Cells, Bispecifics, ADCs, and Beyond
with MD Anderson Cancer Center, UCLA, BeOne Medicines +2 more
Gilead Sciences
Foster City, CA
Large pharma
Biopharmaceutical company with medicines for HIV, viral hepatitis, COVID-19 and cancer, including cell therapies through Kite.
Panel
Thu Jan 28
3:30pm
Part of Track 5: Precision Immunology: Autoimmune & Inflammatory Disease
The Microbial Roots of Autoimmunity: Chronic Infection and Dysbiosis
with NYU Langone Health, Stanford University
Novartis
Basel, Switzerland
Large pharma
Global pharmaceutical company with medicines in cardiovascular, immunology, neuroscience and oncology, and its research arm Novartis Biomedical Research.
Panel
Fri Jan 29
9:30am
Part of Track 2: AI in Drug Discovery & Computational Biology
From Human Evidence to Better Medicines: Choosing the Right Targets
with Bristol Myers Squibb, Valo Health, Genscience +2 more
Novo Nordisk
Bagsværd, Denmark
Large pharma
Global pharmaceutical company focused on diabetes, obesity and other chronic diseases, maker of GLP-1 medicines.
Panel
Fri Jan 29
11:00am
Part of Track 4: Precision Aging, Prevention & Healthspan
From Metabolism to Longevity: GLP-1 and Beyond
with National University of Singapore, Regeneron, UC Irvine

Explore the full PMWC 2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Santa Clara. Leave your work email and we’ll be in touch.

Privacy

Download the full PMWC 2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find buyers from large pharma companies

Tell us what you sell and we’ll find the people at these large pharma companies most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Browse PMWC 2027 by

Exhibit hall

Not affiliated with or endorsed by PMWC or its organizers. Submit a correction